IMRN
Immuron Limited
NASDAQHealthcareBiotechnologyAU
Rating:C
Company Profile
CEO
Steven George Lydeamore
IPO Date
2017-06-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
AU
Immuron Limited
CEO
Steven George Lydeamore
IPO Date
2017-06-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
AU
| 640,824 |
| $0.00 |
| 14 May 2026 | Pollock Daniel Jude | director | Disposed | 0 | $0.00 |
| 14 May 2026 | Pollock Daniel Jude | director | Disposed | 0 | $0.00 |
| 14 May 2026 | Pollock Daniel Jude | director | Disposed | 333,333 | $0.10 |
| 14 May 2026 | Pollock Daniel Jude | director | Disposed | 1,000,000 | $0.08 |
| 4 May 2026 | Brennan Paul Gerard | director, officer: Chairman of the Board | Disposed | 666,667 | $0.18 |
| 4 May 2026 | Brennan Paul Gerard | director, officer: Chairman of the Board | Disposed | 1,000,000 | $0.08 |
| 29 Apr 2026 | Kanellos Jerry | Chief Scientific Officer | Disposed | 0 | $0.00 |
| 29 Apr 2026 | Kanellos Jerry | Chief Scientific Officer | Disposed | 272,134 | $0.00 |